Literature DB >> 20194734

Allele-specific tumor spectrum in pten knockin mice.

Hui Wang1, Matt Karikomi, Shan Naidu, Ravi Rajmohan, Enrico Caserta, Hui-Zi Chen, Maysoon Rawahneh, Julie Moffitt, Julie A Stephens, Soledad A Fernandez, Michael Weinstein, Danxin Wang, Wolfgang Sadee, Krista La Perle, Paul Stromberg, Thomas J Rosol, Charis Eng, Michael C Ostrowski, Gustavo Leone.   

Abstract

Germline mutations in the tumor suppressor gene PTEN (phosphatase and tensin homology deleted on chromosome 10) cause Cowden and Bannayan-Riley-Ruvalcaba (BRR) syndromes, two dominantly inherited disorders characterized by mental retardation, multiple hamartomas, and variable cancer risk. Here, we modeled three sentinel mutant alleles of PTEN identified in patients with Cowden syndrome and show that the nonsense Pten(4-5) and missense Pten(C124R) and Pten(G129E) alleles lacking lipid phosphatase activity cause similar developmental abnormalities but distinct tumor spectra with varying severity and age of onset. Allele-specific differences may be accounted for by loss of function for Pten(4-5), hypomorphic function for Pten(C124R), and gain of function for Pten(G129E). These data demonstrate that the variable tumor phenotypes observed in patients with Cowden and BRR syndromes can be attributed to specific mutations in PTEN that alter protein function through distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194734      PMCID: PMC2841921          DOI: 10.1073/pnas.0912524107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

Authors:  M P Myers; J P Stolarov; C Eng; J Li; S I Wang; M H Wigler; R Parsons; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

Authors:  M R Nelen; W C van Staveren; E A Peeters; M B Hassel; R J Gorlin; H Hamm; C F Lindboe; J P Fryns; R H Sijmons; D G Woods; E C Mariman; G W Padberg; H Kremer
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

3.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Authors:  V Stambolic; M S Tsao; D Macpherson; A Suzuki; W B Chapman; T W Mak
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

6.  Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

Authors:  P L Dahia; D J Marsh; Z Zheng; J Zedenius; P Komminoth; T Frisk; G Wallin; R Parsons; M Longy; C Larsson; C Eng
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

7.  PTEN/MMAC1 mutations in endometrial cancers.

Authors:  J I Risinger; A K Hayes; A Berchuck; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

8.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

9.  Pten in stromal fibroblasts suppresses mammary epithelial tumours.

Authors:  Anthony J Trimboli; Carmen Z Cantemir-Stone; Fu Li; Julie A Wallace; Anand Merchant; Nicholas Creasap; John C Thompson; Enrico Caserta; Hui Wang; Jean-Leon Chong; Shan Naidu; Guo Wei; Sudarshana M Sharma; Julie A Stephens; Soledad A Fernandez; Metin N Gurcan; Michael B Weinstein; Sanford H Barsky; Lisa Yee; Thomas J Rosol; Paul C Stromberg; Michael L Robinson; Francois Pepin; Michael Hallett; Morag Park; Michael C Ostrowski; Gustavo Leone
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

Review 10.  PTEN: one gene, many syndromes.

Authors:  Charis Eng
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

View more
  33 in total

1.  Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.

Authors:  Antonella Papa; Lixin Wan; Massimo Bonora; Leonardo Salmena; Min Sup Song; Robin M Hobbs; Andrea Lunardi; Kaitlyn Webster; Christopher Ng; Ryan H Newton; Nicholas Knoblauch; Jlenia Guarnerio; Keisuke Ito; Laurence A Turka; Andy H Beck; Paolo Pinton; Roderick T Bronson; Wenyi Wei; Pier Paolo Pandolfi
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

2.  PTEN C-terminal deletion causes genomic instability and tumor development.

Authors:  Zhuo Sun; Chuanxin Huang; Jinxue He; Kristy L Lamb; Xi Kang; Tingting Gu; Wen Hong Shen; Yuxin Yin
Journal:  Cell Rep       Date:  2014-02-20       Impact factor: 9.423

3.  Insertion of Alu elements at a PTEN hotspot in Cowden syndrome.

Authors:  Louise Crivelli; Virginie Bubien; Natalie Jones; Jennifer Chiron; Françoise Bonnet; Emmanuelle Barouk-Simonet; Patrice Couzigou; Nicolas Sevenet; Frédéric Caux; Michel Longy
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

4.  Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin.

Authors:  Samy L Habib; Anamika Yadav; Lenin Mahimainathan; Anthony J Valente
Journal:  Genes Cancer       Date:  2011-11

5.  Pten regulates collective cell migration during specification of the anterior-posterior axis of the mouse embryo.

Authors:  Joshua Bloomekatz; Joaquim Grego-Bessa; Isabelle Migeotte; Kathryn V Anderson
Journal:  Dev Biol       Date:  2012-02-11       Impact factor: 3.582

6.  PTEN as a Guardian of the Genome: Pathways and Targets.

Authors:  Xinyi Fan; Jeffrey Kraynak; Jonathan P S Knisely; Silvia C Formenti; Wen H Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

7.  Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.

Authors:  I Jagan; A Fatehullah; R K Deevi; V Bingham; F C Campbell
Journal:  Oncogene       Date:  2012-04-30       Impact factor: 9.867

8.  Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.

Authors:  Jeffrey W Schmidt; Barbara L Wehde; Kazuhito Sakamoto; Aleata A Triplett; Steven M Anderson; Philip N Tsichlis; Gustavo Leone; Kay-Uwe Wagner
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

Review 9.  The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance.

Authors:  Peter Bouwman; Jos Jonkers
Journal:  Nat Rev Cancer       Date:  2012-09       Impact factor: 60.716

10.  Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.

Authors:  Marry H Nieuwenhuis; C Marleen Kets; Maureen Murphy-Ryan; Helger G Yntema; D Gareth Evans; Chrystelle Colas; Pal Møller; Frederik J Hes; Shirley V Hodgson; Maran J W Olderode-Berends; Stefan Aretz; Karl Heinimann; Encarna B Gómez García; Fiona Douglas; Allan Spigelman; Susanne Timshel; Noralane M Lindor; Hans F A Vasen
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.